Product Program year 2020 Source: CMS Open Payments

Emboshield NAV6 system

Device Vascular

Open in the dashboard

General payments

$274,201

968 payments

Research payments

$19,885

3 payments

Through program year 2020, $274,201 in general payments and $19,885 in research payments were reported against Emboshield NAV6 system (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $56,419 279
2019 General $217,783 689
2019 Research $19,885 3

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $274,201 968 payments
Top recipients General payments · program year 2020
  1. Peter Faries Vascular Surgery · New York, NY $9,740 17% · 10 payments
  2. Carlos Mena-Hurtado Cardiovascular Disease · New Haven, CT $8,898 16% · 10 payments
  3. M Niranjan Reddy Interventional Cardiology · Wilmington, OH $6,195 11% · 4 payments
  4. Mahmood Razavi Vascular & Interventional Radiology · Orange, CA $4,000 7% · 2 payments
  5. Christian Bianchi Surgery · Loma Linda, CA $4,000 7% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular Surgery Surgery $14,578 26% · 21 practitioners
  2. Cardiovascular Disease Internal Medicine $13,291 24% · 25 practitioners
  3. Interventional Cardiology Internal Medicine $10,645 19% · 38 practitioners
  4. Vascular & Interventional Radiology Radiology $5,560 10% · 13 practitioners
  5. Surgery $4,932 9% · 4 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $11,767 21% · 5 recipients
  2. California $10,103 18% · 9 recipients
  3. Ohio $10,004 18% · 11 recipients
  4. Connecticut $9,117 16% · 2 recipients
  5. Texas $6,151 11% · 11 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

968 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record